<DOC>
	<DOCNO>NCT01165541</DOCNO>
	<brief_summary>The purpose study test whether take two medicine ( quetiapine mirtazapine ) well help people decrease drink take one medicine alone ( quetiapine ) .</brief_summary>
	<brief_title>A Study Quetiapine Mirtazapine Treatment Alcohol Dependency</brief_title>
	<detailed_description>Alcohol dependence debilitate illness affect almost 8 million people annually current FDA approve medication modestly effective reduce relapse drinking . Because alcohol dependence common , devastating disease , researcher continue search new treatment could effective well tolerate . The development test medication target brain system involve alcohol dependence acute interest patient , clinicians researcher . Studies group animal suggest medication combination weak dopamine D2 receptor antagonism , potent norepinephrine alpha 2 receptor antagonism , norepinephrine reuptake inhibition decrease alcohol drinking . Quetiapine weak D2 antagonist moderate alpha 2 receptor antagonist , primary metabolite , desalkylquetiapine , norepinephrine reuptake inhibitor , medication likely ability decrease alcohol drinking . But , combine mirtazapine , potent alpha 2 antagonist , combination potently decrease alcohol drinking . The propose study base theoretical formulation , well clinical study quetiapine mirtazapine use independently . This open-label , sequential design study one group approximately 20 subject study two treatment condition ; quetiapine alone quetiapine + mirtazapine . The primary objective ass efficacy quetiapine fumarate extended-release ( XR ) alone vs. quetiapine fumarate XR combination mirtazapine reduce weekly percentage day heavy drinking ( 5 drink per drinking day men , 4 drink per drinking day woman ) subject meet DSM-IV criterion alcohol dependency . Participants begin quetiapine fumarate XR target dose 400 mg receive 16 week treatment quetiapine . At week 8 subject begin 9 week mirtazapine add exist regimen quetiapine treatment . Participants also meet medical provider visit encourage compliance study medication attend study visit , review adverse event , set goal reduction drinking . Analyses assess whether treatment quetiapine combination mirtazapine reduce drink treatment quetiapine alone .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Age 1864 2 . The subject meet Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSMIV ) criteria alcohol dependence 3 . The subject seek treatment alcohol dependence desire reduction cessation drink 4 . The subject able verbalize understanding consent form , able provide write informed consent , able verbalize willingness complete study procedure ? 5 . If subject female child bear potential , agree use acceptable method birth control . 6 . The subject able take oral medication , willing adhere medication regimen , willing return regular visit . 7 . The subject able understand write oral instruction English able complete questionnaire require protocol . 8 . The subject breath alcohol concentration ( BAC ) equal 0.000 s/he signing informed consent document .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>